Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy used for weight loss since late April in order to transition patients off compounded drugs, according to the news release
Studies indicate that 60% to 70% of patients report significant improvement by week 8 to 12, though some gastrointestinal sensitivity may persist beyond this period in a smaller subset of users
Eligibility for private prescription typically includes: A BMI of 30 or higher (obesity) A BMI of 27 or higher with at least one weight-related co-morbidity (e.g., high blood pressure, dyslipidemia, obstructive sleep apnea)
Over time, the dose is slowly increased until you reach the maintenance dose that provides the full effect on appetite and weight management
Reading syringe markings correctly prevents dosing errors
In the fibrotic context, metabolic pathways driven by specific amino acids directly support cellular proliferation, differentiation, and excessive ECM deposition, which are hallmark features of fibrogenesis